Showing results (341-350 of 421) with videos related to
Sort By:
Pageof 43
Trials|May 19, 2011
Reporting of complex interventions in clinical trials: development of a taxonomy to classify and describe fall-prevention interventionsSarah E Lamb, Clemens Becker, Lesley D Gillespie, et al.Cell|November 19, 1993
WAF1, a potential mediator of p53 tumor suppressionW S el-Deiry, T Tokino, V E Velculescu, et al.Science (New York, N.Y.)|August 9, 1991
Identification of FAP locus genes from chromosome 5q21K W Kinzler, M C Nilbert, L K Su, et al.Cancer Research|February 24, 2001
Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometryP E Jackson, G S Qian, M D Friesen, et al.In Vivo (Athens, Greece)|May 1, 1994
Synergistic inhibition of AZT-resistant HIV by AZT combined with poly(I):poly(C12U), without synergistic toxicity to bone marrow progenitor cell elementsD Gillespie, H R Hubbell, W A Carter, et al.Science (New York, N.Y.)|October 13, 2001
A phosphatase associated with metastasis of colorectal cancerS Saha, A Bardelli, P Buckhaults, et al.Cancer Research|December 15, 1990
Myxoid liposarcoma with t(12;16) (q13;p11) contains site-specific differences in methylation patterns surrounding a zinc-finger gene mapped to the breakpoint region on chromosome 12S Paulien, C Turc-Carel, P Dal Cin, et al.Science (New York, N.Y.)|March 15, 1991
Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancersK W Kinzler, M C Nilbert, B Vogelstein, et al.Proceedings of the National Academy of Sciences of the United States of America|April 1, 1993
The APC gene product in normal and tumor cellsK J Smith, K A Johnson, T M Bryan, et al.Blood|August 15, 1995
TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignanciesY Sato, Y Suto, J Pietenpol, et al.Pageof 43